Objective. To identify the factors influencing the prevalence of contraception, the additional requirements of women for its noncontraceptive benefits and their realization possibility in case of hyperandrogenic dermopathy. Materials and methods. The mixed method is a counseling procedure based on the ability to offer the wide range of contraceptive methods and devices, from which a user can choose one and further switch to another that best meets her needs during her sexual life. Results. The idea of the mixed method can be used in the combined oral contraceptives line (COCs) under the single umbrella brand Modelle. The additional needs of women suffering from hyperandrogenic dermopathy can be met when using an agent containing ethinyl estradiol (EE) 35 μg and cyproterone acetate (CPA) 2 mg (35ЕЕ/ CPA– Modelle PURE), which can provide the maximum noncontraceptive (therapeutic) benefit. Conclusion. 35EE/CPA is the most suitable contraceptive for women with androgen-dependent skin diseases. © Bionika Media Ltd.